Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: A report of two cases

International Journal of Gynecological Pathology

Volumn 23, Issue 3, 2004, Pages 265-272

  Parker, Robin L ^a,e   Clement, Philip B ^b   Chercover, David J ^c   Sornarajah, Thangaraja ^d   Gilks, C Blake ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c LIONS GATE HOSPITAL   (Canada)

^d Nanaimo Regional General Hospital   (Colombia)

^e FOOTHILLS HOSPITAL   (Canada)

Author keywords

High grade carcinoma; Ovary; Recurrence; Serous borderline tumor

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; GEMCITABINE; PACLITAXEL; TOPOTECAN;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; AXILLARY LYMPH NODE; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE SEVERITY; DYSPNEA; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; INCISIONAL HERNIA; LYMPH NODE METASTASIS; OVARIAN SEROUS BORDERLINE TUMOR; OVARY CARCINOMA; OVARY TUMOR; PLEURA EFFUSION; PRIORITY JOURNAL; SYMPTOM;

CYSTADENOCARCINOMA, SEROUS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS;

EID: 3042743513     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000130049.19643.f6     Document Type: Article

References (25)

1. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scand 1971;50:1-7.
2. Serov SF, Scully RE, Sobin LH. Histologic Typing of Ovarian Tumors In: International Histological Classification of Tumours, no. 9. Geneva: World Health Organization; 1973.
3. Leake JF, Currie JL, Rosenshein NB, et al. Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol 1992;47:150-8.
4. Kennedy AW, Hart WR. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). Cancer 1996;78: 278-86.
5. Gilks CB, Alkushi A, Yue JJ, et al. Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases. Int J Gynecol Pathol 2002;22:29-36.
6. Gershenson DM, Silva EG, Tortolero-Luna G, et al. Serous borderline tumors of the ovary with noninvasive peritoneal implants. Cancer 1998;83:2157-63.
7. Silva EG, Tornos C, Zhuang Z, et al. Tumor recurrence in stage I ovarian serous neoplasms of low malignant potential. Int J Gynecol Pathol 1998;17:1-6.
8. Lee K, Castrillon DH, Nucci MR. Pathologic findings in eight cases of ovarian serous borderline tumors, three with foci of serous carcinoma, that preceded death or morbidity from invasive carcinoma. Int J Gynecol Pathol 2001;20:329-34.
9. Malpica A, Deavers MT, Gershenson D, et al. Serous tumors involving extra-abdominal/extra-pelvic sites after the diagnosis of an ovarian serous neoplasm of low malignant potential. Am J Surg Pathol 2001;25:988-96.
10. Tan LK, Flynn SD, Carcangiu ML. Ovarian serous borderline tumors with lymph node involvement: clinicopathologic and DNA content study of seven cases and review of the literature. Am J Surg Pathol. 1994;18:904-12.
11. Chamberlin MD, Eltabbakh GH, Mount SL, et al. Metastatic serous borderline ovarian tumor in an internal mammary lymph node: a case report and review of the literature. Gynecol Oncol 2001;82:212-5.
12. Eichhorn JH, Bell DA, Young RH, et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns. A study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol 1999;21:397-409.
13. Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000;31:525-6.
14. Aure JC, Hoeg K, Kolstad P. Clinical and histologic studies of ovarian carcinoma. Long-term follow-up of 990 cases. Obstet Gynecol 1971;37:1-9.
15. Prat J, de Nictolis M. Serous borderline tumors of tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Path 2002;26:1111-28.
16. Buttin BM, Herzog TJ, Powell MA, et al. Epithelial ovarian tumors of low malignant potential: the role of microinvasion. Obstet Gynecol 2002;99:11-7.
17. Longacre T, Tazelaar H, Kempson TA. Serous tumors of low malignant potential: Stanford update. Mod Pathol [abstract] 2003; 16:199A.
18. Deavers MT, Gershenson DM, Tortolero-Luna G, et al. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential. Am J Surg Pathol 2002;26:1129-41.
19. Slomovitz BM, Caputo TA, Gretz HF, et al. A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component. Am J Surg Pathol 2002;26:592-600.
20. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996;20:1319-30.
21. Yazigi R, Sandstad J, Munoy AK. Primary staging in ovarian tumors of low malignant potential. Gynecol Oncol 1988;31:402-8.
22. Leake JF, Rader JS, Woodruff JD, et al. Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1991;42:124-30.
23. Ortiz BH, Ailawadi M, Colitti C, et al. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Cancer Res 2001;61:7264-7.
24. Singer G, Oldt R 3rd, Cohen Y, et al. Mutation in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 2003;95:484-6.
25. Hilton JL, Geisler JP, Rathe JA, et al. Inactivation of BRCA1 and BRCA2 in ovarian cancer. J Natl Cancer Inst 2002;94:1396-406.